β-catenin expression also positively correlates with LGR5 over-expression, suggesting the potential involvement of combining LGR5 and β-catenin immunohistochemical markers and degree of expression in the colorectal diagnostic panel for adenoma and carcinoma. Here, LGR5 is linked to carcinoma.